Once for Life

Once for Life

Creating transformational gene therapies and peptide infusions that treat the most prevalent diseases to restore health and renew life


Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive, one-time treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site

 

Latest News:  March 7, 2017: Press release | UNIAPAC FOUNDATION THINK TANK IN PARIS SELECTS RENOVA THERAPEUTICS CEO AND CO-FOUNDER AS KEYNOTE SPEAKER FOR ANNUAL MEETING

  Feb. 27, 2017: Press release | CEO AND CO-FOUNDER OF RENOVA THERAPEUTICS TO PRESENT AT NOVEL CARDIOVASCULAR THERAPEUTICS SUMMIT

  Feb. 21, 2017: Science & Enterprise | Patent Issued for Peptides in Diabetes Gene Therapy

View All News
Subscribe to receive company press releases and announcements
*required